🔎 Trials Near Me

Akèy › Kansè Poumon ki pa ti selil › Ayiti

Etid klinik pou Kansè Poumon ki pa ti selil nan Ayiti

10 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan Ayiti.

Vil nan Ayiti

Tèks ofisyèl etid la (Anglè)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Cenrer - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • ak 5 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Cenrer - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • ak 4 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06498635

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

  • Kaiser Permanente Moanalua Medical Center /ID# 238363, Honolulu
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT04928846

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

  • Kaiser Permanente Moanalua Medical Center /ID# 272916, Honolulu
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06568939

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

  • The Queens Medical Center, Honolulu
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06899126

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Cenrer - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • ak 2 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Cenrer - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • ak 6 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT06116682

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • Spark M. Matsunaga VA Medical Center, Honolulu
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT05297734

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Center - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • ak 10 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

GEMINI-NSCLC: NSCLC Biomarker Study

  • Hawaii Cancer Care, Honolulu
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Feb 5, 2026 · NCT05236114

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.